IQVIA’s CEO: Life science giant ‘delivering results above our financial targets’ Date Published: October 20, 2020 DURHAM – IQVIA Holdings Inc. (IQV) on Tuesday reported third-quarter profit of $101 million. The Durham, North Carolina-based company said…
Hatteras, one of the Triangle’s most important biotech investors, raises more than $137M Date Published: October 16, 2020 Hatteras Venture Partners, one of the Triangle’s most important biotechnology investors, has raised more $137 million for its newest fund,…
Merck’s expansion in Durham reflects huge legacy of Maurice Hilleman Date Published: October 16, 2020 DURHAM — As you walk through the imposing glass front entrance at Merck’s Maurice R. Hilleman Center for Vaccine Manufacturing…
Looking for capital? Small STEM companies can apply for state R&D grants now through Dec. 1 Date Published: October 16, 2020 RESEARCH TRIANGLE PARK — Life sciences companies in North Carolina that have received federal grants for research and development have…
Duke spinout Polarean files NDA for lung diagnostic, possible COVID-19 aid Date Published: October 15, 2020 DURHAM — Polarean, a Duke University spinout, is another step closer to commercializing its proprietary technology for lung imaging. This…
Durham biotech startup inSoma Bio adds $200K to its coffers, seeks additional $690K Date Published: October 14, 2020 DURHAM — Biotech startup InSoma Bio has raised an additional $200,000 in security, according to a filing with the US…
How Durham life science startup Shattuck Labs is revolutionizing cancer therapy Date Published: October 14, 2020 RESEARCH TRIANGLE PARK — Just a mile down the road from the North Carolina Biotechnology Center, Shattuck Labs is changing…
Raleigh-Durham Overtakes Austin as the Hottest Real Estate Area Date Published: October 13, 2020 North Carolina Region’s Life Sciences Research May Help Edge Out Texas Capital. Raleigh-Durham in North Carolina overtook greater Austin, Texas,…
Durham’s Emergo Therapeutics lands $3.5M, seeks another $1.5M Date Published: October 13, 2020 DURHAM — Emergo Therapeutics, a biopharmaceutical startup founded by serial entrepreneur Moise Khayrallah, has raised roughly $3.5 million in equity, …